Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Onkologie
|
June 14, 2008
[Biostatistical issues]
Marcus Hudec
Cancer Investigation
|
January 26, 2011
Prognostic assessment and adjuvant treatment strategies within early-stage, sporadic triple negative breast cancer patients
Robert Königsberg, Georg Pfeiler, Roland Kurzawa, et al.
Surgical Endoscopy
|
June 1, 2012
Hiatal hernia, Barrett's esophagus, and long-term symptom control after laparoscopic fundoplication for gastroesophageal reflux
Johannes Miholic, Joumanah Hafez, Johannes Lenglinger, et al.
Radiology and Oncology
|
August 31, 2012
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience
Martina Baur, Matthias Preusser, Maria Piribauer, et al.
Cancer Investigation
|
July 31, 2008
Cell cycle dysregulation influences survival in high risk breast cancer patients
Robert Königsberg, Olga Rögelsperger, Walter Jäger, et al.
Cancer Letters
|
February 20, 2010
Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods
Robert Königsberg, Margit Gneist, Daniela Jahn-Kuch, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 26, 2011
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Königsberg, Eva Obermayr, Giovanna Bises, et al.
Cancer
|
July 13, 2002
Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial
Martina Baur, Heinz-Roland Kienzer, Johannes Schweiger, et al.
International Journal of Oncology
|
July 31, 2003
Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study
Martina Baur, Reinhard Walter, Axel Gebauer, et al.
Journal of Cancer Research and Clinical Oncology
|
July 20, 2007
A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancer
Martina Baur, Allan T van Oosterom, Véronique Diéras, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Onkologie
|
June 14, 2008
[Biostatistical issues]
Marcus Hudec
Cancer Investigation
|
January 26, 2011
Prognostic assessment and adjuvant treatment strategies within early-stage, sporadic triple negative breast cancer patients
Robert Königsberg, Georg Pfeiler, Roland Kurzawa, et al.
Surgical Endoscopy
|
June 1, 2012
Hiatal hernia, Barrett's esophagus, and long-term symptom control after laparoscopic fundoplication for gastroesophageal reflux
Johannes Miholic, Joumanah Hafez, Johannes Lenglinger, et al.
Radiology and Oncology
|
August 31, 2012
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience
Martina Baur, Matthias Preusser, Maria Piribauer, et al.
Cancer Investigation
|
July 31, 2008
Cell cycle dysregulation influences survival in high risk breast cancer patients
Robert Königsberg, Olga Rögelsperger, Walter Jäger, et al.
Cancer Letters
|
February 20, 2010
Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods
Robert Königsberg, Margit Gneist, Daniela Jahn-Kuch, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 26, 2011
Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
Robert Königsberg, Eva Obermayr, Giovanna Bises, et al.
Cancer
|
July 13, 2002
Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: a phase II trial
Martina Baur, Heinz-Roland Kienzer, Johannes Schweiger, et al.
International Journal of Oncology
|
July 31, 2003
Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study
Martina Baur, Reinhard Walter, Axel Gebauer, et al.
Journal of Cancer Research and Clinical Oncology
|
July 20, 2007
A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancer
Martina Baur, Allan T van Oosterom, Véronique Diéras, et al.
Page
of 2